Get access to our best features

Get access to our best features
Published 10 months ago

US regulator approves teplizumab which can delay the onset of Type 1 diabetes

Summary by Ground News
The world's first treatment which can delay the development of Type 1 diabetes has been licensed in the US.
More
Filters

59 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 77% of the sources are Center
76% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)